Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de valores de Sao Paulo  >  Hypermarcas SA    HYPE3   BRHYPEACNOR0

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Hypermarcas SA : Material Fact - Closing of ASSOLAN, PERFEX and CROSS HATCH selling

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/23/2011 | 10:40pm CEST
HYPERMARCAS S.A.

A Publicly-Held Corporation

CNPJ/MF No. 02.932.074/0001-91
NIRE 35.300.353.251

MATERIAL FACT

HYPERMARCAS S.A. (the "Company" or "Hypermarcas") in compliance with the provisions of Article 157, paragraph 4th, of Law No. 6,404, of December 15, 1976, as amended (the "Brazilian Corporate Law"), and of Brazilian Securities and Exchange Commission - CVM Ruling No. 358, of January 3, 2002, as amended, comes to public to inform that, in addition to the Material Fact released by the Company on December
9th, 2011, and upon the implementation and/or fulfillment, as the case may be, of the precedent conditions, set forth in the "Contrato de Compra e Venda de Quotas e Outras Avenças" (Agreement for the Purchase and Sale of Quotas and Other Covenants - the "Agreement"), executed on December 9th, 2011, alienated, to Química Amparo Ltda. ("Química Amparo"), on the date hereof, of the business of manufacturing and sale of steel wool, steel cloth, synthetic sponges, cleaning cloths and scouring powder, distributed under trademarks "ASSOLAN", "PERFEX" and "CROSS HATCH" (the "Household Cleaning Business"), by means of the transfer of quotas representing the entirety of the capital stock of Assolan Holding Ltda., a special purpose entity established by Hypermarcas exclusively for the purpose of contributing the Household Cleaning Business prior to its transfer to Química Amparo.
São Paulo, December 23, 2011

HYPERMARCAS S.A. Breno Toledo Pires de Oliveira Investor Relations Officer - IRO

SP - 2667080v1

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HYPERMARCAS SA
04/24 J&J, Takeda among interested in Brazil's Hypermarcas, sources say
04/20 HYPERMARCAS : Notice to Shareholders - Dividend Payment
04/20 HYPERMARCAS SA : ex-dividend day for final dividend
03/09 HYPERMARCAS : Notice to Shareholders - Shareholders' Ordinary and Extraordinary ..
03/07 HYPERMARCAS : Notice to the Market - Corporate Events Calendar Update
02/28 HYPERMARCAS : Notice to Shareholders - Dividend Distribution
02/18 HYPERMARCAS : Material Fact - Guidance
02/16 HYPERMARCAS SA : ex-dividend day for interim dividend
01/03 HYPERMARCAS : Notice to the Market - Drugs Recall
2016 COTY INC. (NYSE : COTY) Files An 8-K Completion of Acquisition or Disposition of..
More news
Sector news : Generic Pharmaceuticals
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
04/18 Healthcare Dogs See Medical Care Tops By Yield But Big Pharma Tops By Gains F..
03/30 COTY : A Stable Business With Expanding Cash Flow Is A Beautiful Thing
2015 Coty acquires Brazilian beauty business
2015 Kimberly-Clark on the hunt for Brazilian diaper business
Advertisement
Financials ( BRL)
Sales 2017 3 606 M
EBIT 2017 1 167 M
Net income 2017 927 M
Finance 2017 1 381 M
Yield 2017 3,15%
P/E ratio 2017 20,84
P/E ratio 2018 17,92
EV / Sales 2017 4,88x
EV / Sales 2018 4,36x
Capitalization 18 967 M
More Financials
Chart HYPERMARCAS SA
Duration : Period :
Hypermarcas SA Technical Analysis Chart | HYPE3 | BRHYPEACNOR0 | 4-Traders
Full-screen chart
Technical analysis trends HYPERMARCAS SA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 31,5  BRL
Spread / Average Target 5,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Claudio Bergamo dos Santos Chief Executive Officer & Director
João Alves de Queiroz Filho Chairman
Vivian Karina Trujillo Angiolucci Executive Director-Operations
Martim Prado Mattos Chief Financial Officer
Esteban Malpica Fomperosa Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HYPERMARCAS SA18.23%5 825
OTSUKA HOLDINGS CO LTD-0.77%25 309
SUN PHARMACEUTICAL IND..-10.03%21 132
ONO PHARMACEUTICAL CO...-8.34%12 404
SHANGHAI FOSUN PHARMAC..34.10%10 966
ASPEN PHARMACARE HOLDI..4.00%10 475
More Results